| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Huize Pang, Xiaolu Li, Ziyang Yu, Hongmei Yu, Shuting Bu, Juzhou Wang, Mengwan Zhao, Yu Liu, Yueluan Jiang, Guoguang Fa. Disentangling gray matter atrophy and its neurotransmitter architecture in drug-naïve Parkinson's disease: an atlas-based correlation analysis. Cerebral cortex (New York, N.Y. : 1991). vol 34. issue 10. 2024-10-18. PMID:39420471. |
parkinson's disease is characterized by multiple neurotransmitter systems beyond the traditional dopaminergic pathway, yet their influence on volumetric alterations is not well comprehended. |
2024-10-18 |
2024-10-20 |
Not clear |
| Yuhan Zhang, Yuan Liang, Yixue G. The dopaminergic system and Alzheimer's disease. Neural regeneration research. 2024-09-24. PMID:39314145. |
in addition to the most widely accepted causes, which include excessive aβ aggregation, tau hyperphosphorylation, and deficiency of the neurotransmitter acetylcholine, numerous studies have shown that the dopaminergic system is also closely associated with the occurrence and development of this condition. |
2024-09-24 |
2024-09-26 |
human |
| Chae Yeon Kim, Yunseo Park, Jong Young Namgung, Yeongjun Park, Bo-Yong Par. The macroscale routing mechanism of structural brain connectivity related to body mass index. Human brain mapping. vol 45. issue 13. 2024-09-04. PMID:39230183. |
the neurotransmitter association analysis identified that serotonergic and dopaminergic receptors, as well as opioid and norepinephrine systems, were related to bmi-related alterations in navigation efficiency. |
2024-09-04 |
2024-09-06 |
Not clear |
| Ashini Singh, Suman Sinha, Niraj Kumar Sing. Dietary Natural Flavonoids: Intervention for MAO-B Against Parkinson's Disease. Chemical biology & drug design. vol 104. issue 3. 2024-09-03. PMID:39223743. |
the precise etiology of pd remains elusive, but recent research has shed light on potential factors, including the formation of α-synuclein aggregates, oxidative stress, neurotransmitter imbalances, and dopaminergic neurodegeneration in the substantia nigra pars compacta (snpc) region of the brain, culminating in motor symptoms such as bradykinesia, akinesia, tremors, and rigidity. |
2024-09-03 |
2024-09-05 |
Not clear |
| Heng Chen, Jieshu Li, Zhixing Huang, Xiaoxiao Fan, Xiaofei Wang, Xing Chen, Haitao Guo, Hao Liu, Shuqi Li, Shaojun Yu, Honghong Li, Xinyu Huang, Xuehua Ma, Xinqi Deng, Chunguo Wang, Yonggang Li. Dopaminergic system and neurons: Role in multiple neurological diseases. Neuropharmacology. vol 260. 2024-08-30. PMID:39197818. |
the dopaminergic system is a complex and powerful neurotransmitter system in the brain. |
2024-08-30 |
2024-09-01 |
human |
| Manuel Glauco Carbone, Icro Maremman. Chronic Cocaine Use and Parkinson's Disease: An Interpretative Model. International journal of environmental research and public health. vol 21. issue 8. 2024-08-29. PMID:39200714. |
specifically, we supposed that the chronic administration of cocaine produces significant neurobiological changes, causing a complex dysregulation of various neurotransmitter systems, mainly affecting subcortical structures and the dopaminergic pathways. |
2024-08-29 |
2024-09-01 |
human |
| Ehsan Raeis-Abdollahi, Payman Raise-Abdullahi, Ali Rashidy-Pour, Morvarid Meamar, Hassan Askar. Coffee's protective mechanisms against neurodegeneration. Progress in brain research. vol 288. 2024-08-21. PMID:39168556. |
coffee modulates neurotransmitter systems, including dopaminergic, cholinergic, and glutamatergic pathways implicated in neurodegeneration. |
2024-08-21 |
2024-08-24 |
Not clear |
| Silvia Giménez, Alexandra Millan, Alba Mora-Morell, Noa Ayuso, Isis Gastaldo-Jordán, Marta Pard. Advances in Brain Stimulation, Nanomedicine and the Use of Magnetoelectric Nanoparticles: Dopaminergic Alterations and Their Role in Neurodegeneration and Drug Addiction. Molecules (Basel, Switzerland). vol 29. issue 15. 2024-08-10. PMID:39124985. |
in reviewing dbs studies, this review places particular emphasis on the underlying main neurotransmitter modifications and their specific brain area location, particularly focusing on the dopaminergic system, which plays a critical role in these conditions. |
2024-08-10 |
2024-08-13 |
Not clear |
| María Fernanda Urmeneta-Ortíz, Aldo Rafael Tejeda-Martínez, Orfil González-Reynoso, Mario Eduardo Flores-Sot. Potential Neuroprotective Effect of the Endocannabinoid System on Parkinson's Disease. Parkinson's disease. vol 2024. 2024-08-06. PMID:39104613. |
parkinson's disease (pd) is a neurodegenerative disorder characterized by alterations in motor capacity resulting from a decrease in the neurotransmitter dopamine due to the selective death of dopaminergic neurons of the nigrostriatal pathway. |
2024-08-06 |
2024-08-08 |
Not clear |
| Vasiliki Epameinondas Georgakopoulou, Pagona Sklapani, Nikolaos Trakas, Russel J Reiter, Demetrios A Spandido. Exploring the association between melatonin and nicotine dependence (Review). International journal of molecular medicine. vol 54. issue 4. 2024-08-02. PMID:39092582. |
melatonin may influence neurotransmitter systems involved in addiction, such as the dopaminergic, glutamatergic, serotonergic and endogenous opioid systems. |
2024-08-02 |
2024-08-05 |
Not clear |
| Patrizia Congiu, Monica Puligheddu, Agata Maria Capodiferro, Stella Giulia Falqui, Ludovica Tamburrino, Michela Figorilli, Giuseppe Plazzi, Antonella Gaglian. Narcolepsy and pediatric acute-onset neuropsychiatric syndrome: A case report that suggests a putative link between the two disorders. Sleep medicine. vol 121. 2024-07-30. PMID:39079372. |
in this study, we present the case of a 13-year-old boy with vocal tics and syncopal-like episodes, eventually diagnosed as nt1 and pans, and from this we discuss the hypothesis that both nt1 and pans might belong to the same immunological spectrum, resulting in comparable imbalances in key neurotransmitter axes (i.e., orexinergic and dopaminergic), with conceptual and operational implications, especially with regards to the pharmacological tretament. |
2024-07-30 |
2024-08-02 |
Not clear |
| Natalie Schroyens, Laura Vercammen, Burcu Özcan, Victoria Aurora Ossorio Salazar, Jonas Zaman, Dimitri De Bundel, Tom Beckers, Laura Luyte. No evidence that post-training dopamine D2 receptor agonism affects fear generalization in male rats. Journal of psychopharmacology (Oxford, England). 2024-07-28. PMID:39068641. |
the neurotransmitter dopamine plays an important role in the processing of emotional memories, and prior research suggests that dopaminergic manipulations immediately after fear learning can affect the retention and generalization of acquired fear. |
2024-07-28 |
2024-08-02 |
rat |
| Antoine Deneault, Alexandre Dumais, Marie Désilets, Alexandre Hudo. Natural Language Processing and Schizophrenia: A Scoping Review of Uses and Challenges. Journal of personalized medicine. vol 14. issue 7. 2024-07-27. PMID:39063998. |
it is associated with genetic, neurological, and environmental factors, and linked to dopaminergic hyperactivity and neurotransmitter imbalances. |
2024-07-27 |
2024-07-29 |
human |
| Mehmet Murat Kisla, Murat Yaman, Fikriye Zengin-Karadayi, Busra Korkmaz, Omer Bayazeid, Amrish Kumar, Ravindra Peravali, Damla Gunes, Rafed Said Tiryaki, Emine Gelinci, Gulcin Cakan-Akdogan, Zeynep Ates-Alagoz, Ozlen Kon. Synthesis and Structure of Novel Phenothiazine Derivatives, and Compound Prioritization via In Silico Target Search and Screening for Cytotoxic and Cholinesterase Modulatory Activities in Liver Cancer Cells and In Vivo in Zebrafish. ACS omega. vol 9. issue 28. 2024-07-22. PMID:39035947. |
phenothiazines (ptz) are antipsychotics known to modulate a variety of neurotransmitter activities that include dopaminergic and cholinergic signaling and have been identified as potential anticancer agents in vitro. |
2024-07-22 |
2024-07-24 |
zebrafish |
| Hiroyuki Ichijo, Nguyen Thi Van Trang, Tomoya Nakamur. Topographic Organization of Glutamatergic and GABAergic Parvalbumin Positive Neurons in the Lateral Habenula. eNeuro. 2024-07-03. PMID:38960707. |
to achieve this, we investigated the proportions of the transmitter machinery in lhb pv neurons, including gabaergic, glutamatergic, serotonergic, cholinergic, and dopaminergic neurotransmitter markers, using transcriptome analysis, mrna in situ hybridization chain reaction, and immunohistochemistry. |
2024-07-03 |
2024-07-10 |
mouse |
| Maryam Sardari, Farina Mohammadpourmir, Oveis Hosseinzadeh Sahafi, Ameneh Rezayo. Neuronal biomarkers as potential therapeutic targets for drug addiction related to sex differences in the brain: Opportunities for personalized treatment approaches. Progress in neuro-psychopharmacology & biological psychiatry. 2024-06-29. PMID:38944334. |
sex differences in the neural reward system, mainly through dopaminergic transmission during drug abuse, can be attributed to modifications in neurotransmitter systems and signaling pathways. |
2024-06-29 |
2024-07-02 |
Not clear |
| Tania Arora, Gaurav Sharma, Vikash Prashar, Randeep Singh, Arti Sharma, Harish Changotra, Jyoti Parkas. Mechanistic Evaluation of miRNAs and Their Targeted Genes in the Pathogenesis and Therapeutics of Parkinson's Disease. Molecular neurobiology. 2024-06-01. PMID:38823001. |
pd is mainly caused by the demolition of the primary dopamine neurotransmitter secretory cells and dopaminergic or dopamine secretory neurons in the substantia nigra pars compacta of the midbrain, which are majorly responsible for motor functions. |
2024-06-01 |
2024-06-03 |
Not clear |
| Manxing Zou, Yulu Wu, Yudan Lan, Huanfang Xie, Haopeng Sun, Wenyuan Liu, Feng Feng, Xueyang Jian. Identification and optimization of nitrophenolic analogues as dopamine metabolic enzyme inhibitors for the treatment of Parkinson's disease. Bioorganic chemistry. vol 148. 2024-05-26. PMID:38797066. |
progressive loss of dopaminergic neurons leads to the depletion of the striatal neurotransmitter dopamine, which is the main cause of parkinson's disease (pd) motor symptoms. |
2024-05-26 |
2024-05-31 |
Not clear |
| Peyton Christine Bendis, Sydney Zimmerman, Anna Onisiforou, Panos Zanos, Polymnia Georgio. The impact of estradiol on serotonin, glutamate, and dopamine systems. Frontiers in neuroscience. vol 18. 2024-04-08. PMID:38586193. |
these neurotransmitter systems encompass the serotonergic, dopaminergic, and glutamatergic signaling pathways. |
2024-04-08 |
2024-04-10 |
human |
| Fuyuki Karube, Yang Yang, Kenta Kobayashi, Fumino Fujiyam. Anterograde trans-neuronal labeling of striatal interneurons in relation to dopamine neurons in the substantia nigra pars compacta. Frontiers in neuroanatomy. vol 18. 2024-03-14. PMID:38482378. |
using immunofluorescence against neurotransmitter transporters, almost all axons in the striatum visualized using this approach were confirmed to be dopaminergic. |
2024-03-14 |
2024-03-16 |
Not clear |